Mirum Pharmaceuticals, Inc. (MIRM)
86.21
-1.63
(-1.86%)
USD |
NASDAQ |
Mar 06, 16:00
87.39
+1.18
(+1.37%)
After-Hours: 17:07
Mirum Pharmaceuticals Cash from Investing (TTM) : -23.95M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Insmed, Inc. | -64.58M |
| BridgeBio Pharma, Inc. | -22.34M |
| XOMA Royalty Corp. | -4.892M |
| CorMedix, Inc. | -- |
| ADMA Biologics, Inc. | -21.89M |